Navigation Links
Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis
Date:9/16/2010

HAYWARD, Calif., Sept. 16 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced it has received FDA 510(k) clearance of its Fraxel re:store®Dual for the treatment of actinic keratosis (AKs). The Fraxel re:store Dual system takes the industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of a Thulium laser in the aesthetics market.  The Fraxel re:store Dual treatment provides superior results for the removal of AKs – a common precancerous skin condition caused by sun exposure on the face or other areas of the body.

During a six month clinical study of 21 subjects at several dermatology centers around the country, there was an 83.5% average reduction of AK lesions using the Fraxel re:store Dual's 1927 nm wavelength. Treatments were shown to be effective both on and off the face, including the arms, hands and chest area.  Each subject underwent a series of two to four treatments with the Fraxel re:store Dual that were spaced two to four weeks apart. No adverse reactions occurred for any of the subjects. In addition, the study found improvement in skin texture and pigmentation following a Fraxel treatment.  

"In our study, we found the Fraxel re:store Dual to be the most effective treatment of multiple facial AKs, as it is safe and requires minimal downtime while simultaneously improving other signs of photodamage," said Roy G. Geronemus, MD, Director of the Laser & Skin Surgery Center of New York. "While the 83.5% removal rate was comparable to other topical therapies and AK treatment options, Fraxel was overwhelmingly well-tolerated by all the patients and offers the added benefit of improving a patient
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Solta Medical Announces FDA 510(k) Clearance of New Fraxel re:store(R) Dual Laser System
2. Solta Medical Donates Fraxel re:store(R) Laser System to Grossman Burn Foundation
3. Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
4. Solta Medical, Inc. Announces Fourth Quarter 2009 Results Release Date and Conference Call
5. Solta Medical to Participate in 2nd Annual Lazard Capital Markets Medical Technology Conference
6. Solta Medical and Alma Lasers Resolve Patent Lawsuits
7. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
8. Solta Medical Announces Thermage CPT™ and Fraxel re:store® Dual Systems Receive Health Canada Approval
9. Solta Medical, Inc. Announces Second Quarter 2010 Results Release Date and Conference Call
10. Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... MEETING, Pa. , July 23, 2014 ... INO) today announced successful results from its ... VGX-3100 in women with biopsy-proven cervical intraepithelial ... (HPV) types 16 or 18. Treatment with ... regression of CIN2/3 to CIN1 or no ...
(Date:7/23/2014)... 23, 2014  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: ... on its expertise in opioid antagonists, announced today ... application ("IND") with respect to its naloxone-based opioid ... that it has received an additional commitment from ... of the National Institutes of Health ("NIH"), to ...
(Date:7/23/2014)... Calif. , July 23, 2014  Cardica, Inc. (Nasdaq: ... financial results for its fiscal fourth quarter and year ended ... markets close. Cardica,s management will host a conference call at ... provide an update on the company,s business. Conference ... 7, 2014, at 4:30 p.m. Eastern Time via phone, please ...
Breaking Medicine Technology:Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2
(Date:7/23/2014)... 23, 2014 In preparation for National ... Millennium Treatment Group is providing tips on choosing a ... society ever since man first figured out the process ... has existed since shortly thereafter. Its basis lies in ... then developing a way to combat that problem while ...
(Date:7/23/2014)... If past experience is anything to go by, ... get a lot more recognition for their contributions to ... allowing NPs to provide primary care offer nurses more ... relationships with physicians and administrators, compared with colleagues in ... School of Nursing, published in Health Care Management ...
(Date:7/23/2014)... Asking patients if a suspicious skin lesion is painful ... is likely to be cancerous, according to a new ... Department of Dermatology at Temple University School of Medicine. ... on July 23, 2014, found that nearly 36. ... itching, while 28.2 percent involve pain. Non-melanoma skin cancers ...
(Date:7/23/2014)... 23, 2014 Home Care Assistance ... for seniors, is proud to announce the next installment ... in a wide range of health and wellness-related fields. ... and award-winning author Nancy Kriseman, and will cover the ... prevent burnout by becoming more self-aware. In particular, Nancy ...
(Date:7/23/2014)... News) -- Regularly checking the pulse of a stroke ... "Screening pulse is the method of choice for checking ... have never had a stroke. Our study shows it ... to identify people who might need more thorough monitoring ... Bernd Kallmunzer, of Erlangen University in Germany. ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:New York law offers nurses more recognition, responsibility 2Health News:Research led by Temple's chair of dermatology: Pain and itch may be signs of skin cancer 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2
... www.ibsfl.com ) is proud to announce the recent ... business services, providing advanced technology support services in ... has over 40 employees serving the greater Tampa ... IBS services include IT Consulting and Strategy management, ...
... Measures Helping Those Suffering,from Mental Illness, ARLINGTON, Va., ... someone with a severe mental illness in Louisiana to ... on,June 21, 2008. The law, which unanimously passed both ... effect on August 15., "Nicola,s Law," named after ...
... 8 Healthation, a healthcare,technology company, today ... Software,as a Service agreement with Health Partners, ... members in southeastern Pennsylvania. Health,Partners will implement ... deliver interactive, real-time communication and,administration capabilities to ...
... a U.S. House,Government Oversight Subcommittee Hearing today, a ... mercury pollution by phasing out amalgam,requiring dentists to ... for paying for the clean up technology necessary ... age of amalgam is over," said Michael,Bender, director ...
... is one of the most complex and challenging mental ... with considerable acute and longterm treatment needs and may ... of tremendous social burden for both the individual and ... yet lifelong and clinically severe mood disorder. The disorder ...
... July 8 Kewaunee Scientific,Corporation (Nasdaq: KEQU ... the Russell,Microcap Index after the Russell Investment Group ... indexes on June 27, 2008., Russell indexes ... for both index funds and as benchmarks for ...
Cached Medicine News:Health News:Infinity Business Systems of Tampa Expands Into Sarasota / Bradenton 2Health News:Infinity Business Systems of Tampa Expands Into Sarasota / Bradenton 3Health News:Louisiana Improves Law for Treating Mentally Ill 2Health News:Health Partners Chooses Healthation's AboveHealth Provider Portal 2Health News:Congress Called on to Hold Dental Mercury Polluters Accountable at U.S. House Oversight Hearing 2Health News:The ECNP consensus statement on bipolar depression 2Health News:Kewaunee Scientific Added to Russell Microcap Index 2
... a freestanding cryostat with a unique ... a radial cutting microtome. It has ... range of specimens and materials and ... high biohazard risk laboratories where safe ...
... the new style of Bright cryostat. ... OTF/AS cryostat, the new OTF5000 incorporates ... ever-reliable and powerful 5040 microtome. A ... package deals makes the range of ...
... The Leica ASP300 smart tissue processor ... standards. The ASP300 is a fully enclosed, ... 300 cassette-embedded samples. This new tissue processor ... interface, color touch screen and easy to ...
... are semi-enclosed tissue processors. The Leica TP1020 ... with modern and functionally enhanced design. Gentle ... at all stages of the processing run, ... mechanics in conjunction with a modern user ...
Medicine Products: